No description available.

No description available.

Mouse mammary tumor virus (MMTV), a member of the betaretrovirus family, primarily induces mammary carcinomas in mice. Like human immunodeficiency virus (HIV), MMTV is a complex retrovirus that encodes a viral regulatory protein, Rem. Rem is a 33 kDa glycosylated protein containing an unusually long ER signal peptide (SP). MMTV SP contains all of the functional motifs for the nuclear export of MMTV unspliced/genomic RNA. SP activity requires binding to MMTV RNA. To characterize the minimal Rem-responsive element (RmRE) that overlaps the 3’ LTR, several deletion mutations were introduced in the MMTV-based reporter plasmid, pHMRluc. Results from these mutants in transient transfections revealed a 476-nt RmRE at the junction of the envelope gene and the 3’ LTR. RmRE function was not cell-type specific. The RmRE is predicted to have a complex secondary structure, similar to the Rev-responsive element (RRE) of HIV. Unlike the HIV RRE, the 3’ LTR RmRE occurs in all MMTV mRNAs, and Rem does not increase the export of unspliced RNA of the pHMRluc reporter vector. These results suggest that another RmRE near the 5’-end participates in export of MMTV genomic RNA, whereas the RmRE overlapping the 3’ LTR supports different Rem functions, such as translational regulation. Recent research has shown that SP directs Rem translation to the ER where Rem is cleaved and released into the cytoplasm. Rem mutants with ER signal peptidase cleavage site mutations completely lost function, and mutant proteins were highly unstable and mislocalized. Dominant-negative AAA ATPase p97 and Derlin-1 proteins, which are involved in the ER-associated degradation (ERAD) pathway, inhibited Rem function. Therefore, Rem is a precursor protein that is processed by ER signal peptidases. Rem then manipulates the ERAD system to retrotranslocate SP to the cytoplasm prior to nuclear entry and MMTV RNA binding. Unexpectedly, a commercial control shRNA expression vector, LK0.1, induced additional Rem, HIV-1 Rev and human T-cell leukemia virus type 1 Rex activity (called super-induction). Also, the LK0.1 vector increased protein expression levels of co-transfected genes, and the target of the shRNA was not critical. When the hairpin segment was deleted from LK0.1, the super-induction of Rem activity was greatly reduced. Deletion of cis-acting lentiviral segments also decreased protein expression levels. Although LK0.1 did not affect the levels of interferon-induced genes or eIF-2α phosphorylation, LK0.1 reduced the number of stress granules significantly. Therefore, LK0.1 may induce several cellular signaling pathways, leading to Rem super-induction. This study characterizes the minimal RmRE overlapping the 3’ MMTV LTR and reveals the unique processing of Rem and SP trafficking prior to nucleolar localization. Additional functions of MMTV Rem and other retroviruses may be discovered using studies of cellular events induced by LK0.1. / text

Monoclonal antibodies are well-established as a therapeutic in the biopharmaceutical market, targeting a variety of diseases and with 79 approved products by the United States Food and Drug Administration in December 2019. Therapeutic monoclonal antibodies are commonly produced as recombinant proteins in mammalian cell lines, due to their capacity of post-translational modifications, most notably glycosylation. Furthermore, an identified bottleneck within the production of recombinant proteins is the translocation of nascent proteins from the cytosol into the lumen of the endoplasmic reticulum. The signal peptide, which is located at the N-terminal of nascent proteins, plays a central role in the process of protein secretion. Several studies have shown that optimization of signal peptides is a crucial step for attempting to achieve increased expression of recombinant antibodies in mammalian systems. The aim of this study was to evaluate the expression of three human recombinant antibodies in Human Embryonic Kidney 293 (HEK293) cells by evaluating 16 different signal peptide combinations, consisting of eight heavy chain (HC) and two light chain (LC) signal peptides. The impact goal was an efficient secretion of recombinant antibodies, and thus lower production cost of recombinant antibodies in HEK293 cells. First, 16 HC and LC signal peptide plasmid constructs were generated for each of the three recombinant antibodies. Thereafter, transient gene expression in HEK293 cells were performed at three independent experiments. Finally, the antibody titers were quantified using Biacore concentration analysis. The produced antibody titers for the three studied recombinant antibodies were highly dependent on the used signal peptides. Interestingly, the evaluated HC and LC signal peptide combinations resulted in 3 times higher and 2 times higher antibody titers compared to the original signal peptides used by the Drug Discovery and Development platform at Science for Life Laboratory, for two of the studied antibodies respectively. The results presented in this report further demonstrates the necessity to evaluate signal peptides in order to achieve increased expression of recombinant antibodies in mammalian systems.

O gene MAS1/GAS2, conhecido como \"Magnaporthe Apressoria Specific\", foi identificado como altamente expresso durante a formação do apressório do fungo filamentoso fito patogênico Magnaporthe grisea. Em Aspergillus fumigatus, fungo patogênico oportunista, o gene masA, ortólogo a MAS1/GAS2 foi identificado como upregulated em uma análise transcriptômica exposto a voriconazole e anidulafungina, antifúngicos que afetam a síntese do ergosterol e a parede celular, respectivamente. Em ambos os ortólogos apresentam uma estrutura na região N-terminal da proteína denominada peptídeo sinal o qual neste trabalho foi determinado em uma análise in silico a presença de peptídeo sinal na região N-terminal da proteína. Na caracterização fenotípica de uma linhagem masA - deletada de A. fumigatus não foi identificado alteração estrutural do conidióforo e no seu aspecto macromorfológico. A linhagem masA-deletada é resistente a voriconazol e farnesol, drogas que inibem a síntese de ergosterol e a uma molécula quorum sensing, respectivamente. Ao avaliar o nível de expressão gênica do masA frente a diferentes classes de drogas, foi observado que o gene esta super expresso quando ocorre dano na parede celular, membrana citoplasmática, DNA, inibições na síntese de lipídeos e ácidos graxos e no estresse oxidativo. Na presença de dano na parede celular fúngica causados por anidulafungina, a proteína MasA está localizado na parede celular próximo a ponta da hifa. Adicionalmente, foi capaz de transferir para o meio extra-celular a proteína fusionada a ele, a GFP. Assim, possivelmente MasA participa da via secretória do fungo principalmente em momentos de estresse como o desarranjo da parede celular. A capacidade de secreção natural dos fungos filamentosos tem sido explorada no contexto industrial há décadas. Indicando para este fim, uma possível aplicabilidade para este peptídeo sinal. / The MAS1/GAS2 gene, known as \"Magnaporthe Apressoria Specific\", was identified as highly expressed during the formation of the appressorium phyto pathogenic filamentous fungus Magnaporthe grisea. In Aspergillus fumigatus, opportunistic saprophytic fungus, masA gene orthologous to MAS1/GAS2 was identified as upregulated in a transcriptomic analysis exposed to voriconazole and anidulafungin, antifungals that affect the synthesis of ergosterol and the cell wall, respectively. In both orthologs have a structure at the N-terminus of the protein called signal peptide. During the phenotypic and functional characterization of masA gene in A. fumigatus, was determined on an in silico analysis the presence of signal peptide at the N-terminal region of the protein. In the phenotypic characterization of a strain masA - deleted, no structural change of conidiophores and its macromorfologic aspect was not identified. The characterization masA-deleted strain is resistant to voriconazol and farnesol drugs which inhibit ergosterol synthesis and a quorum sensing molecule, respectively. When evaluating the level of gene expression masA against different class of drugs was observed the super gene is expressed when damage occurs in the cell wall and membrane DNA, the synthesis of lipids and fatty acids, and oxidative stress. In the presence of damage in the fungal cell wall caused by anidulafungin, MasA protein is located near the cell wall and the tip of the hypha and additionally, was able to transfer the protein to the extracellular the protein fused to GFP. Thus, possibly MasA participates in the secretory pathway of the fungus especially in stress of the cell wall. The natural secretion capability of filamentous fungi has been exploited in the industrial context for decades. Indicating for this purpose, a possible applicability for this signal peptide.

The membrane proteins signal peptide peptidase, signal peptide peptidase like and presenilin are intramembrane aspartyl proteases located in the endoplasmic reticulum, plasma membrane and organelle. These membrane proteins are able to catalyze a hydrolytic reaction in a hydrophobic space. The downstream consequences of these reactions impact a variety of cellular functions such as cytokine production, inflammatory responses, embryogenesis, and immune system regulation. Additionally, the aspartyl proteases such as signal peptide peptidase and presenilin, a part of the γ-secretase complex, hydrolyze peptides leading to pathogen maturation and Alzheimer’s disease, respectively. Electron crystallography offers the unique aspect of studying membrane proteins in a near native state. Determining the structures of Haloarcula morismortui and Methanoculleus marisnigri JR1 signal peptide peptidases by electron crystallography may provide insight into how a hydrolysis reaction occurs in a hydrophobic environment and how the protein determines which transmembrane signal peptides to cleave. Additionally, structure determination may help answer questions regarding why human presenilin, part of the γ-secretase complex, incorrectly processes amyloid precursor protein into amyloid-beta peptides leading to Alzheimer’s disease. Such structural data may not only shed light on how amyloid precursor protein is processed but how other proteins are processed by signal peptide peptidase leading to immune responses, cell signaling, and pathogen maturation. In addition, structure-function data may have an impact on pharmaceutical drug designs that targets signal peptide peptidase, signal peptide peptidase like, and/or presenilin. To determine the structure of aspartyl proteases, two archaeal signal peptide peptidases were used for two-dimensional crystallization trials to be able to study their structure by electron crystallography. Haloarcula morismortui and Methanoculleus marisnigri JR1 signal peptide peptidases, both human signal peptide peptidase homologues, were recombinantly over-expressed and purified. During dialysis trials, various lipid-to-protein ratios, sodium chloride concentrations, temperatures, detergents and a variety of other variables were tested. Methanoculleus marisnigri JR1 signal peptide peptidase showed the most promising results in terms of crystallinity. Optimizing dialysis conditions, specifically narrowing the lipid to protein ratio, resulted in two-dimensional crystals. Ordered arrays measuring up to 200 nm x 200 nm were observed. These ordered arrays have been shown to be reproducible amongst multiple batches of purified Methanoculleus marisnigri JR1 signal peptide peptidase. Preliminary projection maps of negatively stained ordered arrays show unit cell dimensions of a = 178 Å, b = 160 Å, γ = 92.0 Å and a = 175 Å, b = 167 Å, γ = 92.0 Å. The monomer measurements are approximately 70 Å by 80 Å. This is the first time a signal peptide peptidase homologue has been crystallized by two-dimensional crystallization.

No description available.

A major obstacle to the development of dengue virus (DENV) vaccines has been the need to immunise concurrently against each of the four DENV serotypes in order to avoid sensitising recipients to developing severe DENV infections. A problem already encountered with live attenuated tetravalent DENV vaccines has been the difficulty in eliciting adequate immune responses against all four DENV serotypes in human hosts. This could have been due to variations in the antigenicity and/or the replication rates of the four DENV serotypes. Non-replicating DNA vaccines avoid the issue of different replication rates. Currently, only DENV-1 and DENV-2 DNA vaccines have been evaluated. In this study, a number of DNA vaccines for each of the four DENV serotypes were developed and their immunogenicity was evaluated in outbred mice. These vaccines included DNA vaccines encoding the DENV prM-E protein genes derived from the four DENV serotypes (pVAX-DEN1, -DEN2, -DEN3 and -DEN4), and DNA vaccines encoding DENV prM and hybrid-E protein genes derived from multiple DENV serotypes. The hybrid-E protein genes were constructed by substituting either domains I and II, domain III, and/or the stem-anchor region from the E protein of one DENV serotype with the corresponding region from another DENV serotype. A number of superior DNA vaccines against each of the four DENV serotypes were identified based on their ability to elicit high titres (≥40, FFURNT50) of neutralising antibodies against the corresponding DENV in mice. The superior DNA vaccines against DENV-1 were pVAX-DEN1, pVAX-C2M2E211, pVAX-C2M2E122 and pVAX-C2M1E122. The superior DNA vaccine against DENV-2 was pVAX-C2M1E122 and the superior DNA vaccines against DENV-3 were pVAX-DEN3 and pVAX-C2M3E344. The superior DNA vaccines against DENV-4 were pVAX-C2M3E344, pVAX-C2M4E434 and pVAX-C2M4E433. Each of these DNA vaccines could provide effective protection against infection by the corresponding DENV serotypes. This is the first study to describe the development of DNA vaccines against DENV-3 and DENV-4. However, mice immunised with a tetravalent DENV DNA vaccine, composed of a DNA vaccine encoding the prM-E protein genes from each of the four DENV serotypes (pVAX-DEN1-4), elicited high titres of neutralising antibodies against DENV-1 and DENV-3 only. Nevertheless, the results from this study suggested that a tetravalent DENV DNA vaccine, composed of pVAX-DEN1, pVAX-C2M1E122, pVAX-DEN3 and pVAX-C2M4E434, may provide effective concurrent protection against infection by each of the four DENV serotypes. In addition, mice immunised with pVAX-C2M1E122, which encoded a hybrid-E protein gene derived from DENV-1 and DENV-2, elicited high titres of anti-DENV-1 and anti-DENV-2 neutralising antibodies, and mice immunised with pVAX-C2M3E344, which encoded a hybrid-E protein gene derived from DENV-3 and DENV-4, elicited high titres of anti-DENV-3 and anti-DENV-4 neutralising antibodies. This result suggested that the co-immunisation of these two hybrid-E DNA vaccines also may provide effective concurrent protection against infection by each of the four DENV serotypes. Extracellular E proteins, believed to be in the form of recombinant subviral particles (RSPs), were recovered from the tissue culture supernatant of all DNA vaccine-transfected mammalian cells by ultracentrifugation, except for cells transfected with the pVAX-C2M2E122 hybrid-E DNA vaccine. Western blotting with the monoclonal antibody 4G2 (flavivirus cross-reactive) demonstrated that the extracellular E proteins expressed by the DNA vaccines were synthesized and cleaved in a manner similar to that of native DENV E proteins. In addition, mammalian cells transfected with pVAX-DEN1, pVAX-DEN2 or pVAX-DEN3 secreted higher amounts of extracellular E proteins than cells transfected with pVAX-DEN4. The amount of extracellular E protein secreted by pVAX-DEN4-transfected cells increased when the c-region of the prM/E signal peptidase cleavage site was made more polar. In contrast, decreasing the polarity of the c-region of the C/prM signal peptidase cleavage site of pVAX-DEN4 resulted in no detectable extracellular E proteins from pVAX-DEN4-transfected cells. This result suggested that the amount of extracellular E proteins secreted by cells transfected with DNA expressing the DENV prM-E protein genes may be dependent of the efficiency of C/prM and prM/E protein cleavages by host-derived signal peptidases. Mice immunised with the mutated pVAX-DEN4, which was capable of expressing large amounts of extracellular E proteins in vitro, produced significantly higher concentrations of Th1-type anti-DENV-4 antibodies than mice immunised with the unmodified pVAX-DEN4, but failed to produce detectable levels of anti-DENV-4 neutralising antibodies. In contrast, increasing the ratio of CpG-S to CpG-N motifs in the pVAX-DEN2 DNA vaccine by incorporating either an additional CpG-S motif, or an antibiotic resistance gene with a high ratio of CpG-S to CpG-N motifs, resulted in a significant increase in both the concentration of Th1-type anti-DENV-2 antibodies and the titres of anti-DENV-2 neutralising antibodies in immunised mice. This result suggested that increasing the amount of CpG-S motifs in DENV DNA vaccines may present an simple and effective approach to increasing the immunogenicity of the DENV DNA vaccines.

O gene MAS1/GAS2, conhecido como \"Magnaporthe Apressoria Specific\", foi identificado como altamente expresso durante a formação do apressório do fungo filamentoso fito patogênico Magnaporthe grisea. Em Aspergillus fumigatus, fungo patogênico oportunista, o gene masA, ortólogo a MAS1/GAS2 foi identificado como upregulated em uma análise transcriptômica exposto a voriconazole e anidulafungina, antifúngicos que afetam a síntese do ergosterol e a parede celular, respectivamente. Em ambos os ortólogos apresentam uma estrutura na região N-terminal da proteína denominada peptídeo sinal o qual neste trabalho foi determinado em uma análise in silico a presença de peptídeo sinal na região N-terminal da proteína. Na caracterização fenotípica de uma linhagem masA - deletada de A. fumigatus não foi identificado alteração estrutural do conidióforo e no seu aspecto macromorfológico. A linhagem masA-deletada é resistente a voriconazol e farnesol, drogas que inibem a síntese de ergosterol e a uma molécula quorum sensing, respectivamente. Ao avaliar o nível de expressão gênica do masA frente a diferentes classes de drogas, foi observado que o gene esta super expresso quando ocorre dano na parede celular, membrana citoplasmática, DNA, inibições na síntese de lipídeos e ácidos graxos e no estresse oxidativo. Na presença de dano na parede celular fúngica causados por anidulafungina, a proteína MasA está localizado na parede celular próximo a ponta da hifa. Adicionalmente, foi capaz de transferir para o meio extra-celular a proteína fusionada a ele, a GFP. Assim, possivelmente MasA participa da via secretória do fungo principalmente em momentos de estresse como o desarranjo da parede celular. A capacidade de secreção natural dos fungos filamentosos tem sido explorada no contexto industrial há décadas. Indicando para este fim, uma possível aplicabilidade para este peptídeo sinal. / The MAS1/GAS2 gene, known as \"Magnaporthe Apressoria Specific\", was identified as highly expressed during the formation of the appressorium phyto pathogenic filamentous fungus Magnaporthe grisea. In Aspergillus fumigatus, opportunistic saprophytic fungus, masA gene orthologous to MAS1/GAS2 was identified as upregulated in a transcriptomic analysis exposed to voriconazole and anidulafungin, antifungals that affect the synthesis of ergosterol and the cell wall, respectively. In both orthologs have a structure at the N-terminus of the protein called signal peptide. During the phenotypic and functional characterization of masA gene in A. fumigatus, was determined on an in silico analysis the presence of signal peptide at the N-terminal region of the protein. In the phenotypic characterization of a strain masA - deleted, no structural change of conidiophores and its macromorfologic aspect was not identified. The characterization masA-deleted strain is resistant to voriconazol and farnesol drugs which inhibit ergosterol synthesis and a quorum sensing molecule, respectively. When evaluating the level of gene expression masA against different class of drugs was observed the super gene is expressed when damage occurs in the cell wall and membrane DNA, the synthesis of lipids and fatty acids, and oxidative stress. In the presence of damage in the fungal cell wall caused by anidulafungin, MasA protein is located near the cell wall and the tip of the hypha and additionally, was able to transfer the protein to the extracellular the protein fused to GFP. Thus, possibly MasA participates in the secretory pathway of the fungus especially in stress of the cell wall. The natural secretion capability of filamentous fungi has been exploited in the industrial context for decades. Indicating for this purpose, a possible applicability for this signal peptide.

No description available.